Arkolith/Insider Trading/BMRN/Form 4

Burkhart Erin

GVP, Chief Accounting OfficerBIOMARIN PHARMACEUTICAL INC (BMRN) · full profile →Form 4 · filed May 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$106K
Net Open-Market Flow
-$106K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2025Sell(S)2K$59.31$106K14K
May 19, 2025Tax withholding(F)996$59.27$59K16K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001048477-25-000060) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML